Bipra Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 51 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Satisfied Charges ₹ 3.21 Cr
- Revenue Growth %
- Profit Growth -20.00%
- Ebitda -25.00%
- Net Worth -27.76%
- Total Assets 129.33%
About Bipra Pharmaceuticals
Bipra Pharmaceuticals Private Limited (BPPL) was founded in India on 22 December 1973 and has a glorious history of 51 years and one month.Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.50 M. The company has closed loans amounting to ₹3.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kalindi Shukla, Aishwarya Shukla, and Anuruddh Singh serve as directors at the Company.
Company Details
-
Location
Kanpur Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231UP1973PTC003831
-
Company No.
003831
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Dec 1973
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Bipra Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aishwarya Shukla
|
Managing Director | 07-Sep-2020 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kalindi Shukla
|
Additional Director | 30-Sep-2024 | Current |
|
Anuruddh Singh
|
Director | 05-Jul-2022 | Current |
Financial Performance of Bipra Pharmaceuticals.
Bipra Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 20% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bipra Pharmaceuticals?
In 2022, Bipra Pharmaceuticals had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Concord Citiprojects Private LimitedKalindi Shukla is a mutual person
-
Divyayu Anusandhan Sansthan Private Limited
Aishwarya Shukla and Anuruddh Singh are mutual person
-
Lssk International Industries Private Limited
Anuruddh Singh is a mutual person
-
Lssk Projects Private Limited
Anuruddh Singh is a mutual person
Charges (Loans)
₹0.50 M
₹32.10 M
Charges Breakdown by Lending Institutions
- State Bank Of India Industrial Estate : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 1993 | State Bank Of India Industrial Estate | ₹0.50 M | Open |
| 27 Feb 1991 | Uttar Pradesh Financial Corporation | ₹3.16 Cr | Satisfied |
| 16 Jun 1990 | Uttar Pradesh Financial Corporation | ₹0.50 M | Satisfied |
How Many Employees Work at Bipra Pharmaceuticals?
Unlock and access historical data on people associated with Bipra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bipra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bipra Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
